Health Condition 1: J308- Other allergic rhinitis
Conditions
Interventions
Intervention1: Itraconazole: 200mg BD Per Oral, for 3 months
Control Intervention1: NOT APPLICABLE: NOT APPLICABLE
Sponsors
AIIMS
Dr Barsha shah
Eligibility
Inclusion criteria
Inclusion criteria: Clinico-radiologically proven AFRS 1 Willing to participate in the study 2 Above 18 years of age
Exclusion criteria
Exclusion criteria: 1 Not willing to participate in the study 2 Below 18 years of age 3 Complicated cases/impending complication 4 Liver disease with deranged blood parameters
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Co-relation of treatment response with pre therapy and post therapy radiological scores. Co-relation of the effectiveness of therapy with pre therapy and post therapy total IgE and aspergillus specific IgE levels. Co-relating the effectiveness of therapy with eosinophil morphological features.Timepoint: 2years | — |
Secondary
| Measure | Time frame |
|---|---|
| Co-relation response of treatment with SNOT-22 scores. Co-relation of treatment response with nasal endoscopic scores. Co-relation of treatment response with eosinophilia and charcot layden crystal in nasal swab. Co-relation of treatment response with other hematological parameters.Timepoint: 2years | — |
Countries
India
Contacts
Public ContactDr Hitesh verma
AIIMS
Outcome results
None listed